XML 25 R7.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Transition adjustment
Common Stock
Accumulated Deficit
Accumulated Deficit
Transition adjustment
Accumulated Other Comprehensive (Loss) Income
Balance (in shares) at Dec. 31, 2021     3,956,492      
Balance at Dec. 31, 2021 $ 67,344   $ 106,479 $ (37,498)   $ (1,637)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 6,161     6,161    
Unrealized holding (loss) gain on available-for-sale securities, net of tax (14,008)         (14,008)
Comprehensive loss (7,847)     6,161   (14,008)
Share-based compensation expense 86   $ 86      
Vesting of restricted stock (in shares)     8,694      
Balance (in shares) at Dec. 31, 2022     3,965,186      
Balance at Dec. 31, 2022 $ 59,583 $ (11,510) $ 106,565 (31,337) $ (11,510) (15,645)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2022-02 [Member]          
Net income (loss) $ (4,179)     (4,179)    
Unrealized holding (loss) gain on available-for-sale securities, net of tax 384         384
Comprehensive loss (3,795)     (4,179)   384
Share-based compensation expense $ 105   $ 105      
Vesting of restricted stock (in shares)     10,887      
Balance (in shares) at Dec. 31, 2023 3,976,073   3,976,073      
Balance at Dec. 31, 2023 $ 44,383   $ 106,670 (47,026)   (15,261)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (39,882)     (39,882)    
Unrealized holding (loss) gain on available-for-sale securities, net of tax (420)         (420)
Comprehensive loss (40,302)     (39,882)   (420)
Share-based compensation expense $ 184   $ 184      
Vesting of restricted stock (in shares)     15,779      
Balance (in shares) at Dec. 31, 2024 3,991,852   3,991,852      
Balance at Dec. 31, 2024 $ 4,265   $ 106,854 $ (86,908)   $ (15,681)